Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
43.30
+0.48 (1.12%)
Mar 9, 2026, 2:18 PM EDT - Market open
Terns Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4,710 | 471 | 401 | 504 | 179 | - | |
| Market Cap Growth | 1242.55% | 17.33% | -20.44% | 182.18% | - | - | |
| Enterprise Value | 4,256 | 99 | 135 | 318 | 1 | - | |
| Last Close Price | 42.82 | 5.54 | 6.49 | 10.18 | 7.07 | - | |
| PS Ratio | - | - | - | - | 178.64 | - | |
| PB Ratio | 13.19 | 1.36 | 1.57 | 1.82 | 1.11 | - | |
| P/TBV Ratio | 16.02 | 1.36 | 1.57 | 1.82 | 1.11 | - | |
| EV/Sales Ratio | - | - | - | - | 1.44 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.19 | |
| Net Debt / Equity Ratio | -1.04 | -1.03 | -1.03 | -1.02 | -1.03 | -0.90 | |
| Net Debt / EBITDA Ratio | 2.72 | 3.51 | 2.57 | 4.58 | 3.36 | 1.69 | |
| Net Debt / FCF Ratio | 3.79 | 5.09 | 3.90 | 5.71 | 3.94 | 2.04 | |
| Asset Turnover | - | - | - | - | 0.01 | - | |
| Quick Ratio | 19.21 | 22.89 | 22.06 | 33.43 | 24.34 | 3.28 | |
| Current Ratio | 19.52 | 23.14 | 22.39 | 33.68 | 24.48 | 3.98 | |
| Return on Equity (ROE) | -29.12% | -29.56% | -33.89% | -27.60% | -43.83% | -68.73% | |
| Return on Assets (ROA) | -19.94% | -20.13% | -23.08% | -17.04% | -23.94% | -39.83% | |
| Return on Capital Employed (ROCE) | -37.90% | -29.20% | -40.00% | -22.30% | -30.90% | -53.30% | |
| Earnings Yield | -2.08% | -18.88% | -22.49% | -11.97% | -28.08% | - | |
| FCF Yield | -1.71% | -14.89% | -16.82% | -9.80% | -23.61% | - | |
| Buyback Yield / Dilution | -22.41% | -11.58% | -97.76% | -58.69% | -7862.47% | -55.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.